Lv2
130 积分 2024-04-23 加入
A cost-effectiveness analysis of the use of oral ibrexafungerp versus fluconazole for acute vulvovaginal candidiasis in the UK NHS primary care service
5个月前
已完结
Comparison of econazole and clotrimazole in the treatment of vulvovaginal candidiasis
8个月前
已关闭
Efficacy and Safety of Oral Ibrexafungerp in Subjects with Vulvovaginal Candidiasis: Pooled Data from Two Phase 3, Randomized, Blinded, Study vs. Placebo (VANISH-303 and VANISH-306)
8个月前
已完结
Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)
8个月前
已完结
Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)
8个月前
已关闭
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
8个月前
已关闭
Comparison of Boric Acid vs. Terconazole in Treatment of RVVC
8个月前
已关闭
FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE
8个月前
已关闭
[Comparative study of itraconazole and fluconazole therapy in vaginal candidosis]
8个月前
已关闭
皖公网安备34019202002308
